Survey and Management of depression, Anxiety and Stress due to COVID-19 fear

Survey on depression, anxiety and stress during Covid-19 in general population of Hassan district and its management with Brahmi (Bacopa monnieri (L.) Pennell) - DAS-COVID-19-AYU

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026952

Enrollment

200

Registered

2020-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Brahmi capsule: Two capsule (500 mg each) twice a day orally Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Subjects within 12 to 60 years of age

Exclusion criteria

Exclusion criteria: Subjects below 12 years and above 60 years

Design outcomes

Primary

Measure	Time frame
Reduction in depression, anxiety and stressTimepoint: 60 days	—

Secondary

Measure	Time frame
Survey on the prevalence of depression, anxiety and stress during COVID-19Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Shailaja U

SDM College of Ayurveda and Hospital, Hassan

profpnrao@gmail.com9448064277

Outcome results